Children with sickle-cell disease are at great risk of serious infections and early mortality.
Our Review investigates the association between sickle-cell disease and invasive bacterial …

Background While secondary pneumococcal pneumonia occurs less commonly after
coronavirus disease 2019 (COVID-19) than after other viral infections, it remains unclear whether …

Background. Winter-seasonal epidemics of pneumococcal disease provide an opportunity
to understand the drivers of incidence. We sought to determine whether seasonality of …

In most settings, sputum is not routinely collected for microbiological diagnosis from children
with lower respiratory disease. To evaluate whether it is feasible and diagnostically useful to …

Background: Community-wide impact of pneumococcal conjugate vaccines (PCV) is
conferred by reductions in vaccine-type nasopharyngeal carriage. We evaluated the impact of …

Background Among older adults, 13-valent pneumococcal conjugate vaccine (PCV13) has
been found efficacious against nonbacteremic pneumonia associated with vaccine-serotype …

Background Protection against disease or colonization from serotypes related to those in
pneumococcal conjugate vaccines (ie cross-protection) vary by serotype; the basis for this …

Background The introduction and adoption of pneumococcal conjugate vaccines (PCVs)
into pediatric national immunization programs (NIPs) has led to large decreases in invasive …

Background Colonisation with Streptococcus pneumoniae can lead to invasive pneumococcal
disease and pneumonia. Pneumococcal acquisition and prevalence of colonisation are …

Pneumococcal conjugate vaccines (PCVs) have been introduced worldwide. However, few
developing countries have high-quality surveillance systems available for monitoring …